Quotes on Sonoma Pharmaceuticals soared over 23% on Tuesday, September 17, following the announcement that the U.S. Food and Drug Administration (FDA) had expanded over-the-counter indications for its flagship product, Microcyn wound cleanser. Details On Tuesday, Sonoma stock gained 23.5% to $5.20 per share on the Nasdaq. It is up…